Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of a locally advanced rectal cancer in a patient who declined surgery.

Literature DB >> 23293703

Management of a locally advanced rectal cancer in a patient who declined surgery.

Raafat Alameddine¹, David Wehbe, Martin Weiser, Neil Segal, Karyn Goodman, Ali Shamseddine, Celina Ang, Ali Haydar, Mustafa Sidani, Fady Geara, Mohamed Naghy, Eileen M O'Reilly, Ghassan K Abou-Alfa.

Abstract

Entities: Disease Species

Year: 2012 PMID： 23293703 PMCID： PMC3533850

Source DB: PubMed Journal: Gastrointest Cancer Res ISSN： 1934-7820

Keyword Cloud
References

× No keyword cloud information.

39 in total

Review 1. Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same.

Authors: R J Mayer
Journal: J Clin Oncol Date: 2001-11-01 Impact factor: 44.544

2. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial.

Authors: Leire Arbea; Rafael Martínez-Monge; Juan A Díaz-González; Marta Moreno; Javier Rodríguez; Jose Luis Hernández; Jesús Javier Sola; Luis Isaac Ramos; Jose Carlos Subtil; Jorge Nuñez; Ana Chopitea; Mauricio Cambeiro; Miren Gaztañaga; Jesús García-Foncillas; Javier Aristu
Journal: Int J Radiat Oncol Biol Phys Date: 2011-11-11 Impact factor: 7.038

3. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis.

Authors: Shandra Bipat; Afina S Glas; Frederik J M Slors; Aeilko H Zwinderman; Patrick M M Bossuyt; Jaap Stoker
Journal: Radiology Date: 2004-07-23 Impact factor: 11.105

4. Thymidine phosphorylase and dihydropyrimidine dehydrogenase protein expression in colorectal cancer.

Authors: E S Collie-Duguid; S J Johnston; L Boyce; N Smith; A Cowieson; J Cassidy; G I Murray; H L McLeod
Journal: Int J Cancer Date: 2001-10-15 Impact factor: 7.396

5. Functional and quality-of-life outcomes in patients with rectal cancer after combined modality therapy, intraoperative radiation therapy, and sphincter preservation.

Authors: D Shibata; J G Guillem; N Lanouette; P Paty; B Minsky; L Harrison; W D Wong; A Cohen
Journal: Dis Colon Rectum Date: 2000-06 Impact factor: 4.585

6. Local staging of rectal cancer with transrectal ultrasound and endorectal magnetic resonance imaging: comparison with histologic findings.

Authors: G F Gualdi; E Casciani; A Guadalaxara; C d'Orta; E Polettini; G Pappalardo
Journal: Dis Colon Rectum Date: 2000-03 Impact factor: 4.585

Management of a locally advanced rectal cancer in a patient who declined surgery.

Review 1. Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same.

2. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial.

3. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis.

4. Thymidine phosphorylase and dihydropyrimidine dehydrogenase protein expression in colorectal cancer.

5. Functional and quality-of-life outcomes in patients with rectal cancer after combined modality therapy, intraoperative radiation therapy, and sphincter preservation.

6. Local staging of rectal cancer with transrectal ultrasound and endorectal magnetic resonance imaging: comparison with histologic findings.

Review 7. Answering patients' needs: oral alternatives to intravenous therapy.

8. Endoluminal ultrasound in the assessment of local invasion in rectal cancer.

Review 9. Applying radiobiological principles to combined modality treatment of head and neck cancer--the time factor.

10. Endoluminal transrectal ultrasonography: accuracy, reliability, and validity.